Method of enhancing cognition
US5837724A · kind A · utility
5Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 11, 1997 |
| Grant date | Nov 17, 1998 |
| Priority date | — |
| Expiry date | Jun 11, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Darifenacin, and its pharmaceutically acceptable salts, are useful in the treatment of cognitive impairment. The invention also discloses the use of combinations of darifenacin, or a pharmaceutically acceptable salt thereof, with an acetylcholinesterase inhibitor, in the treatment of cognitive impairment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.